{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:57:43Z","timestamp":1762347463240,"version":"build-2065373602"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010854","name":"Jiangsu Provincial Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010854","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jocn.2025.111348","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T12:02:40Z","timestamp":1748433760000},"page":"111348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Identification of potential biomarkers and drug targets for meningioma by Mendelian randomisation analysis"],"prefix":"10.1016","volume":"137","author":[{"given":"Shiqing","family":"Du","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keman","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengpeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2025.111348_b0005","unstructured":"ALRUWAILI A A, DE JESUS O. Meningioma [M]. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Orlando De Jesus declares no relevant financial relationships with ineligible companies.; StatPearls Publishing."},{"issue":"21","key":"10.1016\/j.jocn.2025.111348_b0010","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.2217\/fon-2018-0006","article-title":"An overview of meningiomas","volume":"14","author":"Buerki","year":"2018","journal-title":"Future Oncol"},{"issue":"2","key":"10.1016\/j.jocn.2025.111348_b0015","doi-asserted-by":"crossref","first-page":"85","DOI":"10.14791\/btrt.2013.1.2.85","article-title":"Long term clinical outcomes of malignant meningiomas","volume":"1","author":"Lim","year":"2013","journal-title":"Brain Tumor Res Treat"},{"issue":"3","key":"10.1016\/j.jocn.2025.111348_b0020","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","article-title":"Epidemiology and etiology of meningioma","volume":"99","author":"Wiemels","year":"2010","journal-title":"J Neurooncol"},{"issue":"8","key":"10.1016\/j.jocn.2025.111348_b0025","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/ng.3314","article-title":"The support of human genetic evidence for approved drug indications","volume":"47","author":"Nelson","year":"2015","journal-title":"Nat Genet"},{"issue":"383","key":"10.1016\/j.jocn.2025.111348_b0030","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag1166","article-title":"The druggable genome and support for target identification and validation in drug development","volume":"9","author":"Finan","year":"2017","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.jocn.2025.111348_b0035","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1158\/1055-9965.EPI-04-0366","article-title":"Genotyping of patients with sporadic and radiation-associated meningiomas","volume":"14","author":"Sadetzki","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"10.1016\/j.jocn.2025.111348_b0040","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1158\/1055-9965.EPI-09-1151","article-title":"Risk of meningioma and common variation in genes related to innate immunity","volume":"19","author":"Rajaraman","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.jocn.2025.111348_b0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/neuonc\/nop012","article-title":"DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma","volume":"12","author":"Rajaraman","year":"2010","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.jocn.2025.111348_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020690","article-title":"Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis","volume":"22","author":"Bachir","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.jocn.2025.111348_b0055","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/sj.bjc.6604002","article-title":"Nf2\/Merlin: a coordinator of receptor signalling and intercellular contact","volume":"98","author":"Curto","year":"2008","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.jocn.2025.111348_b0060","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3171\/2015.6.JNS15591","article-title":"Genomic landscape of intracranial meningiomas","volume":"125","author":"Bi","year":"2016","journal-title":"J Neurosurg"},{"issue":"6123","key":"10.1016\/j.jocn.2025.111348_b0065","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1126\/science.1233009","article-title":"Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO","volume":"339","author":"Clark","year":"2013","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.jocn.2025.111348_b0070","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","article-title":"New insights into the genetic etiology of Alzheimer's disease and related dementias","volume":"54","author":"Bellenguez","year":"2022","journal-title":"Nat Genet"},{"key":"10.1016\/j.jocn.2025.111348_b0075","doi-asserted-by":"crossref","first-page":"15353","DOI":"10.1038\/ncomms15353","article-title":"Genetic architecture of epigenetic and neuronal ageing rates in human brain regions","volume":"8","author":"Lu","year":"2017","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jocn.2025.111348_b0080","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13073-021-00890-2","article-title":"Multi-tissue neocortical transcriptome-wide association study implicates 8 genes across 6 genomic loci in Alzheimer's disease","volume":"13","author":"Gockley","year":"2021","journal-title":"Genome Med"},{"issue":"9","key":"10.1016\/j.jocn.2025.111348_b0085","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","article-title":"Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression","volume":"53","author":"V\u00f5SA","year":"2021","journal-title":"Nat Genet"},{"issue":"7944","key":"10.1016\/j.jocn.2025.111348_b0090","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"issue":"6509","key":"10.1016\/j.jocn.2025.111348_b0095","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.aaz1776","article-title":"The GTEx Consortium atlas of genetic regulatory effects across human tissues","volume":"369","author":"The","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jocn.2025.111348_b0100","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1038\/s41467-018-04558-1","article-title":"Identifying gene targets for brain-related traits using transcriptomic and methylomic data from blood","volume":"9","author":"Qi","year":"2018","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.jocn.2025.111348_b0105","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ng.3538","article-title":"Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets","volume":"48","author":"Zhu","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.jocn.2025.111348_b0110","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling The False Discovery Rate - A Practical And Powerful Approach To Multiple Testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J Royal Statist Soc, Series B"},{"issue":"15","key":"10.1016\/j.jocn.2025.111348_b0115","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1093\/bioinformatics\/bty147","article-title":"A Bayesian framework for multiple trait colocalization from summary association statistics","volume":"34","author":"Giambartolomei","year":"2018","journal-title":"Bioinformatics"},{"issue":"11","key":"10.1016\/j.jocn.2025.111348_b0120","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1136\/jnnp-2023-331142","article-title":"Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer's disease","volume":"94","author":"Su","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2025.111348_b0125","article-title":"Proteome-wide Mendelian randomization identifies therapeutic targets for ankylosing spondylitis","volume":"15","author":"Zhao","year":"2024","journal-title":"Front Immunol"},{"issue":"6282","key":"10.1016\/j.jocn.2025.111348_b0130","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"Tirosh","year":"2016","journal-title":"Science"},{"issue":"7874","key":"10.1016\/j.jocn.2025.111348_b0135","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41586-021-03850-3","article-title":"A clinically applicable integrative molecular classification of meningiomas","volume":"597","author":"Nassiri","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jocn.2025.111348_b0140","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13073-023-01249-5","article-title":"Annotation of cell types (ACT): a convenient web server for cell type annotation","volume":"15","author":"Quan","year":"2023","journal-title":"Genome Med"},{"issue":"7916","key":"10.1016\/j.jocn.2025.111348_b0145","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/s41586-022-04809-8","article-title":"The renal lineage factor PAX8 controls oncogenic signalling in kidney cancer","volume":"606","author":"Patel","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jocn.2025.111348_b0150","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3389\/fonc.2018.00651","article-title":"Relationships Between Neurofibromatosis-2, Progesterone Receptor Expression, the Use of Exogenous Progesterone, and Risk of Orbitocranial Meningioma in Females","volume":"8","author":"Supartoto","year":"2018","journal-title":"Front Oncol"},{"issue":"15","key":"10.1016\/j.jocn.2025.111348_b0155","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1002\/cncr.35279","article-title":"Evolving concepts in meningioma management in the era of genomics","volume":"130","author":"Hsieh","year":"2024","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.jocn.2025.111348_b0160","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/neuonc\/noab243","article-title":"Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)","volume":"24","author":"Preusser","year":"2022","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2025.111348_b0165","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/978-3-031-29750-2_16","article-title":"Novel Medical Therapies in Meningiomas","volume":"1416","author":"Danish","year":"2023","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"3","key":"10.1016\/j.jocn.2025.111348_b0170","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11060-005-9093-x","article-title":"Salvage chemotherapy with CPT-11 for recurrent meningioma","volume":"78","author":"Chamberlain","year":"2006","journal-title":"J Neurooncol"},{"issue":"7","key":"10.1016\/j.jocn.2025.111348_b0175","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1212\/01.WNL.0000118300.82017.F4","article-title":"Temozolomide for treatment-resistant recurrent meningioma","volume":"62","author":"Chamberlain","year":"2004","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jocn.2025.111348_b0180","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cancergencyto.2008.07.006","article-title":"Methylation status of MGMT gene promoter in meningiomas","volume":"187","author":"de Robles","year":"2008","journal-title":"Cancer Genet Cytogenet"},{"issue":"6","key":"10.1016\/j.jocn.2025.111348_b0185","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3171\/jns.1991.74.6.0861","article-title":"Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone","volume":"74","author":"Grunberg","year":"1991","journal-title":"J Neurosurg"},{"issue":"Suppl 1","key":"10.1016\/j.jocn.2025.111348_b0190","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/humrep\/9.suppl_1.202","article-title":"Role of antiprogestational therapy for meningiomas","volume":"9","author":"Grunberg","year":"1994","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.jocn.2025.111348_b0195","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3171\/jns.2001.94.3.0487","article-title":"Antitumor activity of the growth hormone receptor antagonist pegvisomant against human meningiomas in nude mice","volume":"94","author":"McCutcheon","year":"2001","journal-title":"J Neurosurg"},{"issue":"3","key":"10.1016\/j.jocn.2025.111348_b0200","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/neuonc\/nou279","article-title":"Subsequent neoplasms in survivors of childhood central nervous system tumors: risk after modern multimodal therapy","volume":"17","author":"Tsui","year":"2015","journal-title":"Neuro Oncol"},{"issue":"11","key":"10.1016\/j.jocn.2025.111348_b0205","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/neuonc\/noab150","article-title":"EANO guideline on the diagnosis and management of meningiomas","volume":"23","author":"Goldbrunner","year":"2021","journal-title":"Neuro Oncol"},{"issue":"6563","key":"10.1016\/j.jocn.2025.111348_b0210","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf3066","article-title":"A protein interaction landscape of breast cancer","volume":"374","author":"Kim","year":"2021","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.jocn.2025.111348_b0215","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/ng.3052","article-title":"Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer","volume":"46","author":"Wolpin","year":"2014","journal-title":"Nat Genet"},{"issue":"50","key":"10.1016\/j.jocn.2025.111348_b0220","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2409447121","article-title":"The essential role of TTC28 in maintaining chromosomal stability via HSPA8 chaperone-mediated autophagy","volume":"121","author":"Zhang","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jocn.2025.111348_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175586","article-title":"The role of VEGF in cancer-induced angiogenesis and research progress of drugs targeting VEGF","volume":"949","author":"Ghalehbandi","year":"2023","journal-title":"Eur J Pharmacol"},{"issue":"D1","key":"10.1016\/j.jocn.2025.111348_b0230","doi-asserted-by":"crossref","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","article-title":"DrugBank 6.0: the DrugBank Knowledgebase for 2024","volume":"52","author":"Knox","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"Suppl 1","key":"10.1016\/j.jocn.2025.111348_b0235","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12938-017-0359-2","article-title":"Rational confederation of genes and diseases: NGS interpretation via GeneCards, MalaCards and VarElect","volume":"16","author":"Rappaport","year":"2017","journal-title":"Biomed Eng Online"},{"issue":"D1","key":"10.1016\/j.jocn.2025.111348_b0240","doi-asserted-by":"crossref","first-page":"D877","DOI":"10.1093\/nar\/gkw1012","article-title":"MalaCards: an amalgamated human disease compendium with diverse clinical and genetic annotation and structured search","volume":"45","author":"Rappaport","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.jocn.2025.111348_b0245","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ajhg.2011.08.011","article-title":"Mutations in iron-sulfur cluster scaffold genes NFU1 and BOLA3 cause a fatal deficiency of multiple respiratory chain and 2-oxoacid dehydrogenase enzymes","volume":"89","author":"Cameron","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jocn.2025.111348_b0250","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fimmu.2016.00052","article-title":"Lactate Contribution to the Tumor Microenvironment: Mechanisms, Effects on Immune Cells and Therapeutic Relevance","volume":"7","author":"Romero-Garcia","year":"2016","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.jocn.2025.111348_b0255","first-page":"535","article-title":"Immunoexpression patterns for Hypoxia-inducible Factor-1\u03b1 and von Hippel-Lindau protein, in relation to Hsp90, of human brain tumors","volume":"31","author":"Assimakopoulou","year":"2016","journal-title":"Histol Histopathol"},{"issue":"3","key":"10.1016\/j.jocn.2025.111348_b0260","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1200\/JCO.21.02371","article-title":"Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations","volume":"41","author":"Brastianos","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jocn.2025.111348_b0265","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1522249","article-title":"A novel compound, SYHA1813, inhibits malignant meningioma growth directly by boosting p53 pathway activation and impairing DNA repair","volume":"15","author":"Lan","year":"2025","journal-title":"Front Oncol"},{"issue":"5","key":"10.1016\/j.jocn.2025.111348_b0270","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00280-020-04229-3","article-title":"A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies","volume":"87","author":"Collier","year":"2021","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586825003200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586825003200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:55:07Z","timestamp":1762347307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586825003200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":54,"alternative-id":["S0967586825003200"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2025.111348","relation":{},"ISSN":["0967-5868"],"issn-type":[{"type":"print","value":"0967-5868"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of potential biomarkers and drug targets for meningioma by Mendelian randomisation analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2025.111348","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111348"}}